Assessment of PTeye™ versus FLUOBEAM® LX for parathyroid adenomas: a pilot case–control study - Top-Institutions - MDSpire

Assessment of PTeye™ versus FLUOBEAM® LX for parathyroid adenomas: a pilot case–control study

  • By

  • Theodosios Papavramidis

  • Angeliki Chorti

  • Sohail Bakkar

  • July 29, 2025

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Endocrine Surgery
    • Head and Neck Surgery
    • Endocrinology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrine Surgery
    • Endocrinology
    • Nuclear Medicine

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrine Surgery
    • Head and Neck Surgery
    • Biomedical Engineering

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Endocrine Surgery
    • Endocrinology
    • Surgical Innovation

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Endocrine Surgery
    • Head and Neck Surgery
    • Endocrinology

Original Source(s)

Assessment of PTeye™ versus FLUOBEAM® LX for parathyroid adenomas: a pilot case–control study

  • by Theodosios Papavramidis, Angeliki Chorti, Sohail Bakkar

  • July 29, 2025

Related Content

Zero-echo time MRI: an alternative method for the diagnosis of urinary stones in children

Residual stone fragments: systematic review of definitions, diagnostic standards

Accuracy of frameless stereotactic brain biopsy: a retrospective cohort study with MRI-only and MRI-CT fusion navigation